These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9049961)

  • 1. Fas antigen (CD95) and hematopoietic progenitor cells.
    Nagafuji K; Takenaka K; Shibuya T; Harada M; Niho Y
    Leuk Lymphoma; 1996 Dec; 24(1-2):43-56. PubMed ID: 9049961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fas antigen expression on human hematopoietic progenitor cells].
    Nagafuji K; Takenaka K; Niho Y
    Nihon Rinsho; 1996 Jul; 54(7):1790-6. PubMed ID: 8741668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells.
    Nagafuji K; Shibuya T; Harada M; Mizuno S; Takenaka K; Miyamoto T; Okamura T; Gondo H; Niho Y
    Blood; 1995 Aug; 86(3):883-9. PubMed ID: 7542501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.
    Maciejewski J; Selleri C; Anderson S; Young NS
    Blood; 1995 Jun; 85(11):3183-90. PubMed ID: 7538820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of interferon-gamma and tumor necrosis factor-alpha on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors.
    Welsh JP; Rutherford TR; Flynn J; Foukaneli T; Gordon-Smith EC; Gibson FM
    Hematol J; 2004; 5(1):39-46. PubMed ID: 14745429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver.
    Bárcena A; Park SW; Banapour B; Muench MO; Mechetner E
    Blood; 1996 Sep; 88(6):2013-25. PubMed ID: 8822920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia.
    Maciejewski JP; Selleri C; Sato T; Anderson S; Young NS
    Br J Haematol; 1995 Sep; 91(1):245-52. PubMed ID: 7577642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells.
    Sato T; Selleri C; Anderson S; Young NS; Maciejewski JP
    Br J Haematol; 1997 May; 97(2):356-65. PubMed ID: 9163602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95).
    Takenaka K; Nagafuji K; Harada M; Mizuno S; Miyamoto T; Makino S; Gondo H; Okamura T; Niho Y
    Blood; 1996 Oct; 88(8):2871-7. PubMed ID: 8874183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential.
    Sloand EM; Young NS; Sato T; Kim S; Maciejewski JP
    Exp Hematol; 1998 Oct; 26(11):1093-9. PubMed ID: 9766451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia.
    Selleri C; Sato T; Del Vecchio L; Luciano L; Barrett AJ; Rotoli B; Young NS; Maciejewski JP
    Blood; 1997 Feb; 89(3):957-64. PubMed ID: 9028327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.
    Kim H; Whartenby KA; Georgantas RW; Wingard J; Civin CI
    Stem Cells; 2002; 20(2):174-82. PubMed ID: 11897874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression of CD95/Fas antigen and Bcl-2 on cord blood hematopoietic progenitor cells.
    Ma Y; Zou P
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):24-7. PubMed ID: 12658775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.
    Lewis NR; Pallis M; Russell NH
    Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.
    Selleri C; Sato T; Anderson S; Young NS; Maciejewski JP
    J Cell Physiol; 1995 Dec; 165(3):538-46. PubMed ID: 7593233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and function of CD95/fas antigen and Bcl-2 on cord blood hematopoietic progenitor cells].
    Ma YP; Zhou P; Xiao J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):13-6. PubMed ID: 12513829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas antigen (CD95) expression in peripheral blood progenitor cells from patients with leukaemia and lymphoma.
    Anthony RS; Mckelvie ND; Craig JI; Parker AC
    Leuk Lymphoma; 1998 Aug; 30(5-6):449-58. PubMed ID: 9711907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of Fas (APO-1, CD95) on CD34+ haematopoietic progenitor cells after allogeneic bone marrow transplantation.
    Saheki K; Fujimori Y; Takemoto Y; Kakishita E
    Br J Haematol; 2000 May; 109(2):447-52. PubMed ID: 10848840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interferon-gamma and tumour necrosis factor-alpha on CD95/Fas ligand-mediated apoptosis in human blood eosinophils.
    Luttmann W; Dauer E; Schmidt S; Marx O; Hossfeld M; Matthys H; Virchow JC
    Scand J Immunol; 2000 Jan; 51(1):54-9. PubMed ID: 10632976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the mechanism of enhancing homing efficiency of human hematopoietic stem/progenitor cells into bone marrow after manipulation with tumor necrosis factor alpha in xenotransplanted BALB/c mouse model].
    Dai HS; Gao JT; Zhang TW; Yang Z; Che YZ; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):97-102. PubMed ID: 19563019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.